While taking the drug, most patients ate less and lost weight, leading the developer to seek FDA approval for a new higher-dose indication as a weight loss therapy Wegovy was brought to market last year
DPP-4 inhibitors , including agents like sitagliptin and linagliptin , augment endogenous GLP-1 levels, thereby promoting insulin release
Plasma omega-3 fatty acids and incident diabetes in older adults
& Abraham, R
A tripeptide composed of three different amino acids can be made in 6 different constitutions, and the tetrapeptide shown above (composed of four different amino acids) would have 24 constitutional isomers
Common adverse reactions (adults and pediatric patients 12 years) and WEGOVY side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis